Advertisement
Research ArticleArticle

Off-Target Serine/Threonine Kinase 10 Inhibition by Erlotinib Enhances Lymphocytic Activity Leading to Severe Skin Disorders

Naoko Yamamoto, Masashi Honma and Hiroshi Suzuki
Molecular Pharmacology September 2011, 80 (3) 466-475; DOI: https://doi.org/10.1124/mol.110.070862

Article Information

vol. 80 no. 3 466-475
DOI 
https://doi.org/10.1124/mol.110.070862
PubMed 
21606217
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received December 23, 2010
  • Accepted May 23, 2011
  • Published online August 19, 2011.

Article Versions

Copyright & Usage 
Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Naoko Yamamoto,
  2. Masashi Honma and
  3. Hiroshi Suzuki
  1. Department of Pharmacy, the University of Tokyo Hospital, Faculty of Medicine, the University of Tokyo, Tokyo Japan
  1. Address correspondence to:
    Dr. Masashi Honma, Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail: mhonma-tky{at}umin.ac.jp.
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: May 2011 to May 2023

AbstractFullPdf
May 2011100047
Jun 2011109090
Jul 201150183
Aug 20112101370
Sep 20112712058
Oct 2011991232
Nov 2011911539
Dec 2011681236
Jan 2012691430
Feb 2012521221
Mar 2012721031
Apr 2012471516
May 2012701221
Jun 201221716
Jul 2012401324
Aug 201240410
Sep 2012342048
Oct 2012402638
Nov 2012433135
Dec 2012322227
Jan 2013655137
Feb 2013244827
Mar 2013343120
Apr 2013342327
May 2013282534
Jun 2013344641
Jul 2013276147
Aug 201371721
Sep 2013213126
Oct 2013172727
Nov 2013214140
Dec 2013282424
Jan 2014222836
Feb 2014203147
Mar 2014203634
Apr 2014112830
May 201462132
Jun 2014101926
Jul 2014285231
Aug 201492624
Sep 201481825
Oct 2014192829
Nov 2014152823
Dec 201452425
Jan 2015163618
Feb 2015102928
Mar 2015113918
Apr 2015124317
May 201573624
Jun 2015162614
Jul 201594536
Aug 201593312
Sep 2015132513
Oct 201543212
Nov 2015263223
Dec 2015183920
Jan 2016173026
Feb 2016143422
Mar 2016233118
Apr 201691920
May 2016132422
Jun 2016112623
Jul 2016102730
Aug 2016122018
Sep 201642228
Oct 20166339
Nov 201613515
Dec 201613416
Jan 201715414
Feb 201703413
Mar 201725213
Apr 201743815
May 201723412
Jun 201734218
Jul 201722412
Aug 20172418
Sep 201732915
Oct 201733716
Nov 201753816
Dec 201753715
Jan 201864710
Feb 201832213
Mar 201853613
Apr 201814523
May 201864623
Jun 20181368
Jul 201853822
Aug 20181176
Sep 201823110
Oct 201832115
Nov 201843218
Dec 201831912
Jan 20193438
Feb 20192837
Mar 20191437
Apr 20192018
May 20192865
Jun 201924314
Jul 201922107
Aug 20194527
Sep 20193365
Oct 20192973
Nov 20193148
Dec 20191343
Jan 20201532
Feb 2020211011
Mar 20203330
Apr 20202745
May 20201321
Jun 20202865
Jul 202018126
Aug 202013106
Sep 20202044
Oct 20203434
Nov 20204817
Dec 20202802
Jan 20211945
Feb 20213757
Mar 202170512
Apr 20212455
May 20212354
Jun 2021868
Jul 20212166
Aug 20212844
Sep 20213695
Oct 20213436
Nov 202114811
Dec 20212634
Jan 2022581511
Feb 20225341
Mar 20224416
Apr 20221856
May 20223654
Jun 20225331
Jul 20221734
Aug 20222553
Sep 20222631
Oct 20221812
Nov 2022281012
Dec 2022943
Jan 20232142
Feb 20232323
Mar 20232721
Apr 202318810
May 20231301

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Off-Target Serine/Threonine Kinase 10 Inhibition by Erlotinib Enhances Lymphocytic Activity Leading to Severe Skin Disorders

Naoko Yamamoto, Masashi Honma and Hiroshi Suzuki
Molecular Pharmacology September 1, 2011, 80 (3) 466-475; DOI: https://doi.org/10.1124/mol.110.070862
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement